Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European StudyUri Kopylov, Marc Ferrante, P Steinhagen et al.|Inflammatory Bowel Diseases|2018Cited by 70
DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn’s and Colitis Organisation studyUri Kopylov, Marc Ferrante, Bram Verstockt et al.|Journal of Crohn s and Colitis|2018Cited by 4
Subject IndexGerhard Rogler, Stanislas Mondot, Tomás de Wouters et al.|Digestive Diseases|2013Cited by 0
Falk Symposium SeriesGerhard Rogler, Stanislas Mondot, Tomás de Wouters et al.|Digestive Diseases|2013Cited by 0